TSE:MFC

Manulife Financial (MFC.TO)

60.02
-0.65 (1.07%)
as of Jul 23, 2026, 1:59:53 pm Market Open.
1632 watching
0
Investor Insights
star iconJul 22, 2026, 12:00 am

This summary was created by AI, based on 27 opinions in the last 12 months.

Manulife Financial (MFC) has garnered a mostly positive outlook among various experts, highlighting its competitive positioning within the Canadian financial sector, particularly in comparison to major banks like TD and SLF. Analysts note MFC's ongoing strength in wealth management and healthy growth prospects in Asia, although there are concerns regarding its current valuation, as it trades over 2x book value and exhibits only moderate earnings growth. Despite being classified as slightly overbought, its charts remain healthy, with many recommending caution yet seeing potential for growth in the long run. The company's strong dividend yield and management strategies, particularly in alternative investments, also contribute to a favorable long-term investment story, although short-term volatility may present opportunities for those willing to enter at lower price points.

consensus icon
Consensus
Positive
valuation icon
Valuation
Fair Value
review icon
Similar
SLF,SLF
PAST TOP PICK
(A past top pick Oct 7/03. Up 10%.) Expects their part in the mutual fund scandal will be dealt with very quickly.
WAIT
All the life co's. have moved up in terms of price/earnings ratio. Slightly expensive in the short term. Wait for the John Hancock situation to get cleared up before buying.
BUY
They have a clear growth opportunity outside of Canada.
TOP PICK
Likes their acquisition of John Hancock. It improves their footprint and product line in the US. Strong management team. Buy on any weakness.
BUY
Well-run. The John Hancock acquisition makes a lot of sense.
BUY
Has a long term future. Insurance companies will grow in a 10/15% range, dividends included.
TOP PICK
The John Hancock merger is very good for shareholders. Gives Manulife a footprint into the US. Strong management team. Could be some volatility which will be a buying opportunity.
BUY
Acquisition of John Hancock was a good move. A risk will be if John Hancock shareholders decide to sell their shares, but Manulife has a pretty strong buyback position on this. An interesting stock. Well-positioned for the long term.
DON'T BUY
From a fair market value point of view, it has nothing for you. Not terribly bullish in the short term. What they are doing makes good sense and the growth outlook is reasonable.
TOP PICK
(A top pick Oct 6/03. Up 3½%.) Good synergies with the takeover of John Hancock. Cheap at 11 X earnings.
BUY
Likes life insurance companies and this stock had taken a drop to a good price.
WAIT
The deal with John Hancock doesn't close until next April so would wait closer to that date before buying. Some of the US funds may decide to drop John Hancock shares.
TOP PICK
Has dropped with the takeover of John Hancock. As a value investment, three to five years from now it has the prospects to build back up.
TOP PICK
Likes their acquisition of John Hancock. Have done a good job of integrating in the past.
TOP PICK
John Hancock is a good strategic acquisition/merger. Valuation is very attractive. Stock will remain under pressure for a while.
Showing 2,056 to 2,070 of 2,283 entries